Weeksella virosa DSM 16922

Names | Weeksella virosa DSM 16922 |
---|---|
Accession numbers | NC_015144 |
Background | Weeksella virosa (strain ATCC 43766 / DSM 16922 / JCM 21250 / NBRC 16016 / NCTC 11634 / CL345/78) is a strictly aerobic, chemoorganotrophic, nonsaccharolytic Gram-negative bacterium isolated from genitourinary tract samples, predominantly from women, in North Carolina, USA. W. virosa are also detected by cultural methods in the oral cavity, the genitourinary tract of man, in clinical specimens of pigs, the urine of a cow with bladder carcinoma, and in the midgut of a Brazilian dipteran. W. virosa occurs mainly as an inhabitant of mucosa of warm-blooded animals and healthy man. The cells are rod-shaped with parallel sides and rounded ends. Colonies on nutrient agar appear circular and low convex with entire edges, smooth, shining and mucoid, reaching 2mm in diameter after 24h. Most strains produce a diffusible dark brown pigment on tyrosine-containing agar. W. virosa grows at 42 degrees Celsius but not at 5 degrees Celsius. It is able to utilize beta-hydroxybutyrate as a substrate and to produce indole. W.virosa is susceptible to most beta-lactams, tetracycline, chloramphenicol, nalidixic acid, erythromycin and sulfamethox-azole-trimethoprim. (Adapted from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3072086/pdf/sigs.1603927.pdf). (EBI Integr8) |
Taxonomy | |
Kingdom: | Bacteria |
Phylum: | Bacteroidetes |
Class: | Flavobacteria |
Order: | Flavobacteriales |
Family: | Flavobacteriaceae |
Genus: | Weeksella |
Species: | virosa |
Strain | DSM 16922 |
Complete | Yes |
Sequencing centre | (03-JAN-2011) US DOE Joint Genome Institute, 2800 Mitchell Drive, Walnut Creek, CA 94598-1698, USA (17-FEB-2011) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA |
Sequencing quality | Level 6: Finished |
Sequencing depth | NA |
Sequencing method | 454-GS-FLX, Illumina GAii |
Isolation site | Human urine; USA, North Carolina |
Isolation country | USA |
Number of replicons | 1 |
Gram staining properties | Negative |
Shape | Bacilli |
Mobility | No |
Flagellar presence | No |
Number of membranes | 2 |
Oxygen requirements | Aerobic |
Optimal temperature | NA |
Temperature range | Mesophilic |
Habitat | HostAssociated |
Biotic relationship | Free living |
Host name | Homo sapiens |
Cell arrangement | NA |
Sporulation | Nonsporulating |
Metabolism | NA |
Energy source | Chemoorganotroph |
Diseases | NA |
Pathogenicity | No |
Glycolysis / Gluconeogenesis
Citrate cycle (TCA cycle)
Fatty acid biosynthesis
Synthesis and degradation of ketone bodies
Purine metabolism
Pyrimidine metabolism
Alanine, aspartate and glutamate metabolism
Valine, leucine and isoleucine biosynthesis
Phenylalanine, tyrosine and tryptophan biosynthesis
Selenocompound metabolism
D-Glutamine and D-glutamate metabolism
D-Alanine metabolism
Lipopolysaccharide biosynthesis
Peptidoglycan biosynthesis
One carbon pool by folate
Thiamine metabolism
Riboflavin metabolism
Vitamin B6 metabolism
Nicotinate and nicotinamide metabolism
Pantothenate and CoA biosynthesis
Lipoic acid metabolism
Folate biosynthesis
Terpenoid backbone biosynthesis
Aminoacyl-tRNA biosynthesis
Citrate cycle (TCA cycle)
Fatty acid biosynthesis
Synthesis and degradation of ketone bodies
Purine metabolism
Pyrimidine metabolism
Alanine, aspartate and glutamate metabolism
Valine, leucine and isoleucine biosynthesis
Phenylalanine, tyrosine and tryptophan biosynthesis
Selenocompound metabolism
D-Glutamine and D-glutamate metabolism
D-Alanine metabolism
Lipopolysaccharide biosynthesis
Peptidoglycan biosynthesis
One carbon pool by folate
Thiamine metabolism
Riboflavin metabolism
Vitamin B6 metabolism
Nicotinate and nicotinamide metabolism
Pantothenate and CoA biosynthesis
Lipoic acid metabolism
Folate biosynthesis
Terpenoid backbone biosynthesis
Aminoacyl-tRNA biosynthesis